Kirkland & Ellis LLP

Counting private equity sponsors and leading companies among its key roster of clients, Kirkland & Ellis LLP continues to handle a high volume of large-scale merger reviews that attract close scrutiny from competition authorities. The practice handles the full spectrum of merger control work, from high-volume filings to complex, contentious matters. Coordination with European teams remains a regular feature of the practice on transactions with cross-border clearance requirements. In Washington DC, Matthew Reilly draws on senior FTC experience to advise on merger reviews that face serious enforcement risk, and is regularly brought in on transactions heading toward Second Request and potential litigation. Daniel Zach is noted for his track record of leading high-profile investigations and litigated challenges across the pharma, life sciences, defence and technology sectors. Recent lateral hires have added further depth to the bench, including Maria Raptis from Skadden, Arps, Slate, Meagher & Flom LLP, alongside DC-based Benjamin Able from the DOJ Antitrust Division and Colin Herd from the FTC. Attorneys are based in New York unless otherwise stated.